UCLA CTSI K Workshop - February 4, 2016
Learn to navigate through the possible career development awards (CDAs) available to you and which you should target.
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Leader, Research Education, Training and Career Development Program
Grant Proposals (SF 424): K08-K23 Applications and Individual CDAsUCLA CTSI
UCLA CTSI K Workshop - February 4, 2016
Isidro B. Salusky, MD
Distinguished Professor of Pediatrics at UCLA Chief, Division of Pediatric Nephrology
Director, Clinical Translational Research Center
Associate Dean of Clinical Research
UCLA CTSI K Workshop - February 4, 2016
Mariko Ishimori, MD
Associate Health Sciences Clinical Professor of Medicine
Cedars-Sinai Medical Center CTSI Associate Leader UCLA Clinical & Translational Science Institute
Isidro Salusky, MD “Writing the NIH K Award”
Distinguished Professor of Pediatrics at UCLA
Chief, Division of Pediatric Nephrology
Director, Clinical Translational Research Center
Associate Dean of Clinical Research
UCLA CTSI K Workshop
Learn to navigate through the possible career development awards (CDAs) available to you and which you should target.
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Leader, UCLA CTSI Workforce Development
Presentation date: February 09, 2017
K99/R00 Awards - Pathways to IndependenceUCLA CTSI
UCLA CTSI K Workshop - February 4, 2016* (*updated Feb 1, 2017)
Christopher Evans, PhD
Professor of Psychiatry and Biobehavioral Sciences at UCLA
Director, Brain Research Institute
Navigating the NIH K Award Process (July 25, 2013)UCLA CTSI
Navigating the NIH K Award Process
Carol Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Program Leader, Research Education, Training and Career Development Program
UCLA CTSI KL2 Award, New NIH Guidelines on Rigor & TransparencyUCLA CTSI
Explanation of the UCLA CTSI KL2 Award and the new NIH guidelines on Rigor & Premise.
Mitchell D. Wong, MD, PhD
Professor of Medicine at UCLA
Executive Co-Director, Specialty Training and Advanced Research (STAR) Program
Director, UCLA CTSI KL2 Program
Presentation date: February 09, 2017
Writing the NIH K Award
Isidro B. Salusky, MD
Distinguished Professor of Pediatrics at UCLA
Chief, Division of Pediatric Nephrology
Director, Clinical Translational Research Center
Associate Dean of Clinical Research
Grant Proposals (SF 424): K08-K23 Applications and Individual CDAsUCLA CTSI
UCLA CTSI K Workshop - February 4, 2016
Isidro B. Salusky, MD
Distinguished Professor of Pediatrics at UCLA Chief, Division of Pediatric Nephrology
Director, Clinical Translational Research Center
Associate Dean of Clinical Research
UCLA CTSI K Workshop - February 4, 2016
Mariko Ishimori, MD
Associate Health Sciences Clinical Professor of Medicine
Cedars-Sinai Medical Center CTSI Associate Leader UCLA Clinical & Translational Science Institute
Isidro Salusky, MD “Writing the NIH K Award”
Distinguished Professor of Pediatrics at UCLA
Chief, Division of Pediatric Nephrology
Director, Clinical Translational Research Center
Associate Dean of Clinical Research
UCLA CTSI K Workshop
Learn to navigate through the possible career development awards (CDAs) available to you and which you should target.
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Leader, UCLA CTSI Workforce Development
Presentation date: February 09, 2017
K99/R00 Awards - Pathways to IndependenceUCLA CTSI
UCLA CTSI K Workshop - February 4, 2016* (*updated Feb 1, 2017)
Christopher Evans, PhD
Professor of Psychiatry and Biobehavioral Sciences at UCLA
Director, Brain Research Institute
Navigating the NIH K Award Process (July 25, 2013)UCLA CTSI
Navigating the NIH K Award Process
Carol Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Program Leader, Research Education, Training and Career Development Program
UCLA CTSI KL2 Award, New NIH Guidelines on Rigor & TransparencyUCLA CTSI
Explanation of the UCLA CTSI KL2 Award and the new NIH guidelines on Rigor & Premise.
Mitchell D. Wong, MD, PhD
Professor of Medicine at UCLA
Executive Co-Director, Specialty Training and Advanced Research (STAR) Program
Director, UCLA CTSI KL2 Program
Presentation date: February 09, 2017
Writing the NIH K Award
Isidro B. Salusky, MD
Distinguished Professor of Pediatrics at UCLA
Chief, Division of Pediatric Nephrology
Director, Clinical Translational Research Center
Associate Dean of Clinical Research
Carol Mangione, MD, MSPH “Navigating the NIH K Award Process”UCLA CTSI
Carol Mangione, MD, MSPH “Navigating the NIH K Award Process”
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Program Leader, Research Education, Training and Career Development Program
Writing the NIH K Award (SF 424): K08-K23 Applications & Individual CDAsUCLA CTSI
Presented by:
Isidro B. Salusky, MD
Distinguished Professor of Pediatrics at UCLA
Chief, Division of Pediatric Nephrology
Director, Clinical Translational Research Center
Associate Dean of Clinical Research
Presentation from: February 09, 2017
Mitchell Wong, M.D. Ph.D.
Professor of Medicine
Executive Vice Chair for Research Training in the Department of Medicine.
Director of the CTSI KL2 Program,
Executive co-Director of the UCLA Specialty Training and Advanced Research (STAR) Program,
Co-Director of the UCLA NRSA Primary Care Fellowship
Navigating the NIH K Award Process (2021)UCLA CTSI
Navigating the NIH K Award Process
Presented by Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Chief, Division of General Internal Medicine and Health Services Research
Associate Director, UCLA CTSI
Leader, UCLA CTSI Workforce Development
Navigating the NIH K Award Process (July 2015)UCLA CTSI
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Program Leader, Research Education, Training and Career Development Program (CTSI-ED)
K99/R00 Awards - Pathways to IndependenceUCLA CTSI
Dr. Evans provides considerations in applying for a K99 Award. Provided by the UCLA Clinical and Translational Science Institute. More information at https://ctsi.ucla.edu/education/pages/edtools and https://ctsi.ucla.edu/education/pages/kprogram
Presenter:
Christopher Evans, PhD
Professor of Psychiatry and Biobehavioral Sciences at UCLA
Director, Brain Research Institute
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence"...UCLA CTSI
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence"
Presented by:
Christopher Evans, PhD
Professor of Psychiatry and Biobehavioral Sciences at UCLA
Director, Brain Research Institute
Presentation date: February 09, 2017
UC Research Exchange (UC ReX) & Los Angeles Data Repository (LADR) UCLA CTSI
Learn more about the clinical data set tools, LADR and UC ReX available to UCLA CTSI, its partners and other UCs.
Marianne Zachariah
Administrator, Informatics Program
UCLA Clinical and Translational Science Institute
Learn to navigate through the possible K Awards / Career Development Awards (CDAs) available to you and which you should target. Provided by UCLA Clinical and Translational Science Institute.
Presenter:
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Leader, UCLA CTSI Workforce Development
Presentation date: February 09, 2017
UCLA CTSI KL2 Resources
Presented by Mitchell D. Wong, MD, PhD
Professor of Medicine at UCLA
Executive Co-Director, Specialty Training and Advanced Research (STAR) Program
Director, UCLA CTSI KL2 Program
UCLA CTSI KL2 Award, New NIH Guidelines on Rigor & TransparencyUCLA CTSI
Explanation of the UCLA CTSI KL2 Award and the NIH guidelines. Provided by the UCLA Clinical and Translational Science Institute. More information is available at https://ctsi.ucla.edu/education/pages/kprogram
Presenter:
Mitchell D. Wong, MD, PhD
Professor of Medicine at UCLA
Executive Co-Director, Specialty Training and Advanced Research (STAR) Program
Director, UCLA CTSI KL2 Program
A Tactical Approach to Writing Your Grant Application (2020)UCLA CTSI
William Parks, PhD
Professor of Medicine at Cedars-Sinai Medical Center and UCLA
Associate Dean for Graduate Research Education
Scientific Director, Women’s Guild Lung Institute
"NIH Electronic Grant Proposals (SF 424) – K23 and K08 Individual Career Develop Awards"
Isidro Salusky, MD
Distinguished Professor of Pediatrics
Division Chief, Pediatric Nephrology
Director, UCLA CTSI Clinical Translational Research Center
Associate Dean for Clinical Research
Navigating the NIH K Award Process and Choosing Your Mentorship Team (2023)UCLA CTSI
Navigating the NIH K Award Process and Choosing Your Mentorship Team
Presented by
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Chief, Division of General Internal Medicine and Health Services Research
Leader, UCLA CTSI Workforce Development
Carol Mangione, MD, MSPH “Navigating the NIH K Award Process”UCLA CTSI
Carol Mangione, MD, MSPH “Navigating the NIH K Award Process”
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Program Leader, Research Education, Training and Career Development Program
Writing the NIH K Award (SF 424): K08-K23 Applications & Individual CDAsUCLA CTSI
Presented by:
Isidro B. Salusky, MD
Distinguished Professor of Pediatrics at UCLA
Chief, Division of Pediatric Nephrology
Director, Clinical Translational Research Center
Associate Dean of Clinical Research
Presentation from: February 09, 2017
Mitchell Wong, M.D. Ph.D.
Professor of Medicine
Executive Vice Chair for Research Training in the Department of Medicine.
Director of the CTSI KL2 Program,
Executive co-Director of the UCLA Specialty Training and Advanced Research (STAR) Program,
Co-Director of the UCLA NRSA Primary Care Fellowship
Navigating the NIH K Award Process (2021)UCLA CTSI
Navigating the NIH K Award Process
Presented by Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Chief, Division of General Internal Medicine and Health Services Research
Associate Director, UCLA CTSI
Leader, UCLA CTSI Workforce Development
Navigating the NIH K Award Process (July 2015)UCLA CTSI
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Program Leader, Research Education, Training and Career Development Program (CTSI-ED)
K99/R00 Awards - Pathways to IndependenceUCLA CTSI
Dr. Evans provides considerations in applying for a K99 Award. Provided by the UCLA Clinical and Translational Science Institute. More information at https://ctsi.ucla.edu/education/pages/edtools and https://ctsi.ucla.edu/education/pages/kprogram
Presenter:
Christopher Evans, PhD
Professor of Psychiatry and Biobehavioral Sciences at UCLA
Director, Brain Research Institute
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence"...UCLA CTSI
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence"
Presented by:
Christopher Evans, PhD
Professor of Psychiatry and Biobehavioral Sciences at UCLA
Director, Brain Research Institute
Presentation date: February 09, 2017
UC Research Exchange (UC ReX) & Los Angeles Data Repository (LADR) UCLA CTSI
Learn more about the clinical data set tools, LADR and UC ReX available to UCLA CTSI, its partners and other UCs.
Marianne Zachariah
Administrator, Informatics Program
UCLA Clinical and Translational Science Institute
Learn to navigate through the possible K Awards / Career Development Awards (CDAs) available to you and which you should target. Provided by UCLA Clinical and Translational Science Institute.
Presenter:
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Leader, UCLA CTSI Workforce Development
Presentation date: February 09, 2017
UCLA CTSI KL2 Resources
Presented by Mitchell D. Wong, MD, PhD
Professor of Medicine at UCLA
Executive Co-Director, Specialty Training and Advanced Research (STAR) Program
Director, UCLA CTSI KL2 Program
UCLA CTSI KL2 Award, New NIH Guidelines on Rigor & TransparencyUCLA CTSI
Explanation of the UCLA CTSI KL2 Award and the NIH guidelines. Provided by the UCLA Clinical and Translational Science Institute. More information is available at https://ctsi.ucla.edu/education/pages/kprogram
Presenter:
Mitchell D. Wong, MD, PhD
Professor of Medicine at UCLA
Executive Co-Director, Specialty Training and Advanced Research (STAR) Program
Director, UCLA CTSI KL2 Program
A Tactical Approach to Writing Your Grant Application (2020)UCLA CTSI
William Parks, PhD
Professor of Medicine at Cedars-Sinai Medical Center and UCLA
Associate Dean for Graduate Research Education
Scientific Director, Women’s Guild Lung Institute
"NIH Electronic Grant Proposals (SF 424) – K23 and K08 Individual Career Develop Awards"
Isidro Salusky, MD
Distinguished Professor of Pediatrics
Division Chief, Pediatric Nephrology
Director, UCLA CTSI Clinical Translational Research Center
Associate Dean for Clinical Research
Navigating the NIH K Award Process and Choosing Your Mentorship Team (2023)UCLA CTSI
Navigating the NIH K Award Process and Choosing Your Mentorship Team
Presented by
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Chief, Division of General Internal Medicine and Health Services Research
Leader, UCLA CTSI Workforce Development
How to Anticipate and Plan for an R Grant Application. (2022)UCLA CTSI
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Chief, Division of General Internal Medicine and Health Services Research
Professor of Medicine and Public Health at UCLA
Leader, UCLA CTSI Workforce Development
How to Anticipate and Plan for an R Grant Application - 2023UCLA CTSI
CTSI R Workshop: How to Anticipate and Plan for an R Grant Application.
Presented by Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Chief, Division of General Internal Medicine and Health Services Research
Professor of Medicine and Public Health at UCLA
Leader, UCLA CTSI Workforce Development
How to Anticipate and Plan for an R Grant Application (2020)UCLA CTSI
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Chief, Division of General Internal Medicine and Health Services Research
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Leader, UCLA CTSI Workforce Development
"Perspectives from the NIH Study Section"
Keith C. Norris, MD, FASN, FACP
Professor and Executive VP for Research and Health Affairs, Charles R. Drew University
Assistant Dean for Clinical and Translational Science, UCLA
Perspectives from the NIH Study Section
Keith C. Norris, MD, FASN, FACP
Professor and Executive VP for Research and Health Affairs, Charles R. Drew University
Assistant Dean for Clinical and Translational Science, UCLA
K99 Award: the NIH "Pathway to Independence"UCLA CTSI
UCLA CTSI K Workshop - July 28, 2022
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence" presented by Dr. Christopher Evans, PhD
NIH Loan Repayment Program (LRP) Info Session - 9/26/23UCLA CTSI
The UCLA CTSI and DGSOM Office of Physician Scientist Career Development held this webinar to provide information on the NIH Loan Repayment Program (LRP). This funding is designed to recruit and retain highly qualified health professionals into biomedical or biobehavioral research careers. The LRPs counteract financial pressure by repaying up to $50,000 annually of a researcher's qualified educational debt in return for a commitment to engage in NIH mission-relevant research.
UCLA CTSI KL2 Award
Mitchell Wong, MD, PhD
Associate Professor of Medicine
Executive Co-Director, Specialty Training and Advanced Research (STAR) Program
Director, UCLA CTSI KL2 Program
Co-Program Leader, Research Education, Training and Career Development Program
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence"...UCLA CTSI
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence"
Presented by Christopher Evans, PhD
Professor of Psychiatry and Biobehavioral Sciences at UCLA
Co-Director, UCLA CTSI KL2 Program
NIH Electronic Grant Proposals (SF 424)
K 08 - K - 23 Grant Applications
Individual Career Development Awards
Isidro B. Salusky, MD
Distinguished Professor of Pediatrics
Division Chief, Pediatric Nephrology
Director, Clinical Translational Research Center
Associate Dean for Clinical Research
David Geffen School of Medicine at UCLA
How to Craft the "Significance” & "Innovation" Sections of a Grant Applicatio...UCLA CTSI
William Parks, PhD
Professor of Medicine at Cedars-Sinai Medical Center and UCLA
Associate Dean for Graduate Research Education
Scientific Director, Women’s Guild Lung Institute
Ask an NIH Program Officer: Tips and Tools for New & Early-Stage ResearchersNorbert Tavares, Ph.D.
Tips and tools for new and early-career researchers to navigate the NIH funding system. Presented at the Experimental Biology Conference in Orlando FL, 4/8/19. Opening panel presentation by Norbert Tavares, Ph.D., AAAS Science Policy Fellow and Program Manager at the National Cancer Institute at NIH.
What Next: When You are not Funded on the First Round - 2023UCLA CTSI
CTSI R Workshop: What Next: When You are not Funded on the First Round.
Scott G. Filler, MD
Professor of Medicine at Lundquist Institute/Harbor-UCLA and UCLA
Leader, CTSI Pilot Translational and Clinical Studies Program
Co-Leader, CTSI KL2 Institutional Development Core
How to Write the “Specific Aims” Section - 2023UCLA CTSI
CTSI R Workshop: How to Write the “Specific Aims” Section of a Grant Application.
Tannaz Moin, MD, MBA, MSHS
Associate Professor of Medicine at UCLA
AssociateDirector, UCLA Specialty Training and Advanced Research (STAR) Program
How to Structure the “Approach” Section (Basic Science)UCLA CTSI
CTSI R Workshop: How to Structure the “Approach” Section of a Grant Application
Scott G. Filler, MD
Professor of Medicine at Lundquist Institute/Harbor-UCLA and UCLA
Leader, CTSI Pilot Translational and Clinical Studies Program
Co-Leader, CTSI KL2 Institutional Development Core
How to Craft the "Significance” & "Innovation" [Filler] - 2023UCLA CTSI
CTSI R Workshop: How to Craft the "Significance” & "Innovation" Sections of a Grant Application.
Scott G. Filler, MD
Professor of Medicine at Lundquist Institute/Harbor-UCLA and UCLA
Leader, CTSI Pilot Translational and Clinical Studies Program
Co-Leader, CTSI KL2 Institutional Development Core
How to Craft the "Significance” & "Innovation" - 2023UCLA CTSI
CTSI R Workshop: How to Craft the "Significance” & "Innovation" Sections of a Grant Application
William Parks, PhD
Professor of Medicine at Cedars-Sinai Medical Center and UCLA
Associate Dean for Graduate Research Education
Scientific Director, Women’s Guild Lung Institute
A Tactical Approach to Writing Your Grant Application (HSR) - 2023UCLA CTSI
CTSI R Workshop: A Tactical Approach to Writing Your Grant Application (HSR)
Tannaz Moin, MD, MBA, MSHS
Associate Professor of Medicine at UCLA
Associate Director, UCLA Specialty Training and Advanced Research (STAR) Program
A Tactical Approach to Writing Your Grant Application - 2023UCLA CTSI
CTSI R Workshop: A Tactical Approach to Writing Your Grant Application
William Parks, PhD
Professor of Medicine at Cedars-Sinai Medical Center and UCLA
Associate Dean for Graduate Research Education
Scientific Director, Women’s Guild Lung Institute
How to Write the “Specific Aims” Section of a Grant Application (Basic Scienc...UCLA CTSI
CTSI R Workshop: How to Write the “Specific Aims” Section of a Grant Application (Basic Science
Scott G. Filler, MD
Professor of Medicine at Lundquist Institute/Harbor-UCLA and UCLA
Leader, CTSI Pilot Translational and Clinical Studies Program
Co-Leader, CTSI KL2 Institutional Development Core
Writing the NIH K Award – Research Plan
Presented by
Sumeet S. Chugh, MD
Price Professor and Associate Director, Smidt Heart Institute
Director, Division of Artificial Intelligence in Medicine
Cedars-Sinai Medical Center
K Awards – Common Pitfalls and UCLA CTSI KL2 Resources (2023)UCLA CTSI
K Awards – Common Pitfalls and UCLA CTSI KL2 Resources
Presented by Elizabeta Nemeth, PhD
Professor of Medicine at UCLA
Director, UCLA Center for Iron Disorders
Co-Director, UCLA CTSI KL2 Program
Writing the NIH K Award – Candidate Information and Career Development Plan, ...UCLA CTSI
Writing the NIH K Award – Candidate Information and Career Development Plan,
How Reviewers Evaluate K Awards, and Common Critiques from NIH K Study Sections
Presented by O. Kenrik Duru, MD, MSHS
Professor of Medicine at UCLA
Investigator (Disparities), UCLA CTSI Special Populations
Model Attribute Check Company Auto PropertyCeline George
In Odoo, the multi-company feature allows you to manage multiple companies within a single Odoo database instance. Each company can have its own configurations while still sharing common resources such as products, customers, and suppliers.
Instructions for Submissions thorugh G- Classroom.pptxJheel Barad
This presentation provides a briefing on how to upload submissions and documents in Google Classroom. It was prepared as part of an orientation for new Sainik School in-service teacher trainees. As a training officer, my goal is to ensure that you are comfortable and proficient with this essential tool for managing assignments and fostering student engagement.
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
Synthetic Fiber Construction in lab .pptxPavel ( NSTU)
Synthetic fiber production is a fascinating and complex field that blends chemistry, engineering, and environmental science. By understanding these aspects, students can gain a comprehensive view of synthetic fiber production, its impact on society and the environment, and the potential for future innovations. Synthetic fibers play a crucial role in modern society, impacting various aspects of daily life, industry, and the environment. ynthetic fibers are integral to modern life, offering a range of benefits from cost-effectiveness and versatility to innovative applications and performance characteristics. While they pose environmental challenges, ongoing research and development aim to create more sustainable and eco-friendly alternatives. Understanding the importance of synthetic fibers helps in appreciating their role in the economy, industry, and daily life, while also emphasizing the need for sustainable practices and innovation.
The French Revolution, which began in 1789, was a period of radical social and political upheaval in France. It marked the decline of absolute monarchies, the rise of secular and democratic republics, and the eventual rise of Napoleon Bonaparte. This revolutionary period is crucial in understanding the transition from feudalism to modernity in Europe.
For more information, visit-www.vavaclasses.com
This is a presentation by Dada Robert in a Your Skill Boost masterclass organised by the Excellence Foundation for South Sudan (EFSS) on Saturday, the 25th and Sunday, the 26th of May 2024.
He discussed the concept of quality improvement, emphasizing its applicability to various aspects of life, including personal, project, and program improvements. He defined quality as doing the right thing at the right time in the right way to achieve the best possible results and discussed the concept of the "gap" between what we know and what we do, and how this gap represents the areas we need to improve. He explained the scientific approach to quality improvement, which involves systematic performance analysis, testing and learning, and implementing change ideas. He also highlighted the importance of client focus and a team approach to quality improvement.
How to Make a Field invisible in Odoo 17Celine George
It is possible to hide or invisible some fields in odoo. Commonly using “invisible” attribute in the field definition to invisible the fields. This slide will show how to make a field invisible in odoo 17.
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdfTechSoup
In this webinar you will learn how your organization can access TechSoup's wide variety of product discount and donation programs. From hardware to software, we'll give you a tour of the tools available to help your nonprofit with productivity, collaboration, financial management, donor tracking, security, and more.
We all have good and bad thoughts from time to time and situation to situation. We are bombarded daily with spiraling thoughts(both negative and positive) creating all-consuming feel , making us difficult to manage with associated suffering. Good thoughts are like our Mob Signal (Positive thought) amidst noise(negative thought) in the atmosphere. Negative thoughts like noise outweigh positive thoughts. These thoughts often create unwanted confusion, trouble, stress and frustration in our mind as well as chaos in our physical world. Negative thoughts are also known as “distorted thinking”.
1. Navigating the K Award Process
CTSI K Award Workshop
February 4, 2016
Carol M. Mangione, MD, MSPH
Barbara A. Levey and Gerald S. Levey
Professor of Medicine and
Health Policy & Management
2. Types of CDAs
• K01: For clinicians or Ph.D.s in the fields of
epidemiology and outcomes research, must have
accomplished independent research experience
after earning your degree.
• K08: Salary and research support for full time
supervised career development in health related
research that does not involve patients.
• K12/KL2: Support awarded to an institution for
the development of independent scientists.
• K23: Salary and research support for full time
supervised career development in patient
oriented research, must have completed specialty
training
3. Types of CDAs
• K25: Supports career development of investigators with
quantitative scientific and engineering backgrounds
outside of biology or medicine who have made a
commitment to focus their research endeavors on
behavioral and biomedical research (basic or clinical).
• K99/R00: Provides an opportunity for scientists to receive
both a 1 to 2 year “mentored” K (phase 1) and a 3 year
independent “R” (phase 2) in the same award. To qualify,
you must have a clinical or research doctorate and no
more than four years of postdoctoral research training at
the time of application.
• See the K award wizard to help you select the correct
mechanism:
• http://grants.nih.gov/training/careerdevelopmentawards.
htm
• Diversity Supplements: After administrative review these
are added onto a funded grant, with extra resources for
the trainee to develop and conduct mentored research
8. Time Commitment and
Salary Caps
• Time Commitment:
• 75% full time effort (50% for surgeons in
some specialties)
• Salary Cap increased to:
• 95K for K08 and K23 and 105K for K02
(May 18, 2012, NOT-NS-12-018)
• There is variability and exceptions at the
Institute level, check the website for
your institute
9. Additional Salary Support while
on a CDA (NOT-OD-08-065)
• During the last two years of a mentored career
development award (K01, K07, K08, K22, K23,
K25, KL2), NIH will permit you to receive
concurrent salary support from any peer-
reviewed grant from any federal agency, if you
meet the following criteria:
– You are a PI on a competing research project grant, or
director of a sub-project on a multi-component grant,
from NIH or another Federal agency.
– Your K award is active when the R, P or U grant is
submitted
– Under those circumstances, you may reduce your K
award's time and effort to 50% person months.
10. NIH Policy Concerning: Leave, Temporary
Adjustments to % Effort, and Part-Time
Appointments
• See NOT-OD-09-036
• Developed to accommodate personal or
family situations such as parental leave,
child care, elder care, medical conditions,
or a disability.
• Will not be approved to accommodate job
opportunities, clinical practice, clinical
training, or joint appointments
11. More on Part Time Status…
• Must submit a written request to the NIH awarding
institute requesting a reduction in effort to less than
75% for up to 12 continuous months
• Will be considered on a case-by-case basis
• In no case will it be permissible to work at less than
50% effort (equivalent to 6 person-months)
• At the time of application and initial award, must meet
the full-time appointment requirement as well as the
minimum 75% effort requirement
• Must commit at least 75% effort (of the part-time
appointment) to research and career development
activities.
12. NIH Resubmissions (NOT-OD-14-074)
NIH and AHRQ will accept a new application following an unsuccessful
resubmission application. The new application need not demonstrate
substantial changes in scientific direction compared to previously reviewed
submissions, and must not contain an introduction to respond to the critiques
from the previous review.
NIH will not accept duplicate or highly overlapping applications under review at
the same time(NOT-OD-09-100). This means that the NIH will not accept: -
• a new application that is submitted before issuance of the summary
statement from the review of an overlapping resubmission application.
• a resubmission application that is submitted before issuance of the summary
statement from the review of the previous new application.
• an application that has substantial overlap with another application pending
appeal of initial peer review (NOT-OD-11-101).
The NIH will not accept a resubmission that is submitted later than 37 months
after the receipt date of the initial new, renewal, or revision application.
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-10-
140.html#sthash.MUZVeRSX.dpuf
13. Governmental Alphabet Soup
• NIH - National Institutes of Health
• AHRQ - Agency for Healthcare Research
and Quality
• PCORI – Patient Centered Outcomes
Research Institute
• RFA - Request for application
• RFP - Request for proposals
• PA - Program announcement
14. Approach of the NIH
U.S. Government
Congressional
Appropriation
NIH funds allocated to
each institute
Investigator Initiated Institute Initiated
RO-1
K awards
NRSA
RFP - contracts
RFA - grants
15. Organization of the NIH
• Establish relationships with the program officers
at the institutes in your research area
• Each Institute handles career development
funds in slightly different ways – Review their
websites
• 2 parts:
– Program- Includes the Institutes that set the
research priorities
– Review - CSR or Center for Scientific Review
• Evaluates the scientific merits of the proposals
• http://www.csr.nih.gov
16. NIH Review Process
• Takes about 9-10 months at best
• Initial Administrative review
• Importance of the title and “steering the
proposal”
• Peer Review - Study sections made up of scientists
from universities and other institutions
• Most applications are not funded on the first
round
• For detailed information on success rates:
http://report.nih.gov/success_rates/index.aspx
17. Approach of the NIH
RO-1, NRSA, or K applications
CSR assigns the application to
1) Study Section
2) An Institute
Study Section assigns a
Priority Score (1-9)
Institute uses the Priority Score
to rank the application among those
received from various study sections
Advisory Council reviews
the priorities
Applications are funded in order of priority
until the money runs out!
18. NIH grant application scoring system
• 9-point rating for the impact/priority score with 1
= Exceptional and 9 = Poor.
• Ratings in whole numbers only
19. NIH Review Process
• Final decision by Council -- where the
previous contact with administrators can
matter!
• If successful, final administrative
procedures to set up the budget
21. Significance
• Does this study address an important
problem? Do you make a compelling case?
• If the aims of the application are achieved,
how will scientific knowledge be advanced??
• What will be the effect of these studies on
the concepts or methods that drive this
field? How might this change the field? Be
convincing!!!
22. Approach
• Are the conceptual framework, design, methods,
and analyses adequately developed, well-
integrated, and appropriate to the aims?
• Does the applicant acknowledge potential
problem areas and consider alternative tactics?
• Is there an appropriate work plan included?
• Does the project include plans to measure
progress toward achieving the stated objectives?
How will you know when you are half way there?
23. Innovation
• Does the project employ novel concepts,
approaches or methods?
• Are the aims original and innovative?
• Does the project challenge or advance
existing paradigms or develop new
methodologies or technologies?
24. Investigator
• Is the investigator appropriately trained
and well suited to carry out this work?
• Is the work proposed appropriate to the
experience level of the principal
investigator and other significant
investigator participants?
• Is there a prior history of conducting (fill in
area) research? Does not fund empty
aspirations!
25. Environment
• Does the scientific environment contribute to
the probability of success?
• Do the proposed experiments take advantage
of unique features of the scientific
environment or employ useful collaborative
arrangements?
• Is there evidence of institutional support?
• Is there an appropriate degree of commitment
and cooperation of other interested parties as
evidence by letters detailing the nature
and extent of the involvement?
26. Budget
• Are all requests justified scientifically
• Do special items have quotes
• Is the project feasible with the given
budget
– Low budget often viewed worse than high
budget,
• Low budget - applicant does not understand what is
need to do the work - may worsen the score
– -High budget -: will get cut but usually not
worsen score, unless really high
27. Other Key areas
• Protection of human subjects (closely
reviewed)
– HIPAA plan
– data and safety monitoring plan
– inclusion of women, minorities & children
– recruitment plan
– evidence (not plan) of proposed
partnerships
• Animal welfare
• Biohazards
• Evaluation
30. NIH CAREER DEVELOPMENT (K) GRANTS
Competing Applications, Awards, Success Rates and Total Funding
by NIH Institutes/Centers and Activity Code
Made with Direct Budget Authority Funds
Fiscal Year 2010
Number of
Applications
Reviewed
Number of
Applications
Awarded
Success Rate Total
Funding
K01 465 185 39.8% $24,377,709
K08 480 211 44.0% $30,787,581
K23 558 211 37.8% $31,635,065
See Table #204 at “report.nih.gov/FileLink.aspx?rid=551” for more details.
31. NIH CAREER DEVELOPMENT (K) GRANTS
Competing Applications, Awards, Success Rates and Total Funding
by NIH Institutes/Centers and Activity Code
Made with Direct Budget Authority Funds
Fiscal Year 2011
Number of
Applications
Reviewed
Number of
Applications
Awarded
Success
Rate
Total
Funding
K01 441 151 34.2% $19,779,309
K08 425 177 41.6% $26,461,116
K23 599 203 33.9% $31,036,760
See Table #204 at “report.nih.gov/FileLink.aspx?rid=551” for more details.
32. NIH CAREER DEVELOPMENT (K) GRANTS
Competing Applications, Awards, Success Rates and Total Funding
by NIH Institutes/Centers and Activity Code
Made with Direct Budget Authority Funds
Fiscal Year 2012
Number of
Applications
Reviewed
Number of
Applications
Awarded
Success
Rate
Total
Funding
K01 522 168 32.2% $22,586,026
K08 371 157 42.3% $23,254,142
K23 555 203 36.6% $31,820,630
See Table #204 at “report.nih.gov/FileLink.aspx?rid=551” for more details.
33. NIH CAREER DEVELOPMENT (K) GRANTS
Competing Applications, Awards, Success Rates and Total Funding
by NIH Institutes/Centers and Activity Code
Made with Direct Budget Authority Funds
Fiscal Year 2013
Number of
Applications
Reviewed
Number of
Applications
Awarded
Success
Rate
Total
Funding
K01 483 160 33.1% $21,515,902
K08 346 124 35.8% $19,659,367
K23 555 178 32.1% $28,555,388
See Table #204 at “report.nih.gov/FileLink.aspx?rid=551” for more details.
34. NIH CAREER DEVELOPMENT (K) GRANTS
Competing Applications, Awards, Success Rates and Total Funding
by NIH Institutes/Centers and Activity Code
Made with Direct Budget Authority Funds
Fiscal Year 2014
Number of
Applications
Reviewed
Number of
Applications
Awarded
Success
Rate
Total
Funding
K01 579 200 35% $28,425,228
K08 394 158 40% $24,953,839
K23 524 201 38% $32,567,685
See Table #204 at “report.nih.gov/FileLink.aspx?rid=551” for more details.